These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 126386)

  • 1. The concentration of 5-methoxytryptamine in rat brain and its effects on behaviour following its peripheral injection.
    Green AR; Hughes JP; Tordoff AF
    Neuropharmacology; 1975 Aug; 14(8):601-6. PubMed ID: 126386
    [No Abstract]   [Full Text] [Related]  

  • 2. The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.
    Marsden CA; Curzon G
    Psychopharmacology (Berl); 1978 Apr; 57(1):71-6. PubMed ID: 149328
    [No Abstract]   [Full Text] [Related]  

  • 3. Involvement of 5-hydroxytryptamine and dopamine neurones in the behavioural effects of alpha-methylytryptamine.
    Marsden CA
    Neuropharmacology; 1980 Aug; 19(8):691-8. PubMed ID: 6448356
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles.
    Marsden CA; Curzon G
    Neuropharmacology; 1977; 16(7-8):489-94. PubMed ID: 144245
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of reserpine, para-chlorophenylalanine, 5,6-dihydroxytryptamine and fludiazepam on the head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice.
    Nakamura M; Fukushima H
    J Pharm Pharmacol; 1978 Apr; 30(4):254-6. PubMed ID: 24719
    [No Abstract]   [Full Text] [Related]  

  • 6. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the influence of 6-hydroxydopamine, alpha methyltyrosine and 5,6-dihydroxy-tryptamine, p-chlorophenylalanine on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC; Jain KM
    Indian J Physiol Pharmacol; 1974; 18(4):324-9. PubMed ID: 4282853
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1977 Mar; 29(3):135-8. PubMed ID: 15075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tryptamine in the behavioural changes caused by a monoamine oxidase inhibitor and L-tryptophan [proceedings].
    Curzon G; Marsden CA
    Br J Pharmacol; 1977 Jun; 60(2):307P-308P. PubMed ID: 880472
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
    Boullin DJ; Green AR
    Adv Biochem Psychopharmacol; 1976; 15():127-40. PubMed ID: 15408
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of some tryptamine derivatives on brain monoamines and their precursor amino acids.
    Leonard BE; Shallice SA
    Neuropharmacology; 1972 May; 11(3):373-84. PubMed ID: 4262001
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1974 Nov; 13(10-11):949-59. PubMed ID: 4437730
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan.
    Marsden CA; Curzon G
    Neuropharmacology; 1979 Feb; 18(2):159-64. PubMed ID: 431783
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin agonist actions of p-chlorophenylalanine.
    Sloviter RS; Drust EG; Connor JD
    Neuropharmacology; 1978 Dec; 17(12):1029-33. PubMed ID: 154622
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of tryptamine on the behavior of mice.
    Sugimoto Y; Yamada J; Horisaka K
    J Pharmacobiodyn; 1986 Jan; 9(1):68-73. PubMed ID: 2940357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 17. A role for brain protein in the process by which brain serotonin and certain other indolealkylamines produce behaviourally excitant effects in the rat.
    Grahame-Smith DG
    Clin Sci; 1972 Feb; 42(2):11P-12P. PubMed ID: 5058563
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of histamine and H1 and H2-receptor antagonists on wet-dog-shake episodes in rats induced with tranylcypromine and 5-methoxytryptamine.
    Kolasa K; Kleinrok Z; Rajtar G; Juszkiewicz M
    Acta Physiol Pol; 1984; 35(3):225-30. PubMed ID: 6152672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1975 Feb; 14(2):107-13. PubMed ID: 1153078
    [No Abstract]   [Full Text] [Related]  

  • 20. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.